A study published in Nature Microbiology now shows for the first time that Candida auris uses a CO₂-based metabolic strategy to survive in the nutrient-poor conditions of the skin and to better tolerate antifungal therapies – especially amphotericin B (AMB).24. Dezember 2025
News Caravel Bio Wins $7.8M NSF Grant to Pioneer Next-Generation Protein EngineeringHealthradar17. Oktober 2025 What You Should Know: – Caravel Bio, the first joint platform for protein discovery and delivery that enables new applications of…
